Cancer pain, which results from either the malignancy itself or from the therapies used to treat the malignancy, is a complex condition that is often poorly managed. The heterogeneous nature of cancer pain can present challenges for the oncologist as well as for primary care providers, who often care for patients who are in remission but still have lingering cancer or cancer treatment related pain. This activity uses an online, case-based approach to discuss strategies for the optimal management of cancer pain for both the oncologist and primary care clinician.
This activity has been designed to meet the educational needs of oncologists, primary care physicians, physician assistants, nurse practitioners, and other health care providers involved in the diagnosis and management of cancer pain.
Upon completion of this activity, participants should be able to:
- Differentiate between neuropathic and non-neuropathic pain in patients with cancer
- Explain the next steps in treating patients with cancer pain who do not respond adequately to an initial treatment regimen
- Outline the difference between breakthrough pain and pain that is poorly controlled using around-the-clock analgesics
- Develop a management plan for cancer survivors with pain
- Determine when a referral to a pain medicine specialist is most appropriate
AMA PRA Category 1 Credit(s)TM
Penn State College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This activity is co-sponsored by Curatio CME Institute, an ACCME-accredited provider.
Penn State College of Medicine designates this enduring material for a maximum of 1.75 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Charles E. Argoff, MDProgram Chair
Professor of Neurology
Albany Medical College
Director, Comprehensive Pain Program
Albany Medical Center
Albany, New York
Glenn J. Lesser, MD, FACP
Professor of Internal Medicine
Section on Hematology and Oncology
Director, Medical Neuro-Oncology
Clinical Program Director, Wake Forest School of Medicine
Brain Tumor Center of Excellence
Wake Forest Baptist Health
Winston-Salem, North Carolina
Bill H. McCarberg, MD
Adjunct Assistant Clinical Professor
University of California, San Diego
Founder, Chronic Pain Management Program
San Diego, California
Charles E. Argoff, MD, has disclosed the following relevant financial relationships:
Consultant: Cephalon, Depomed, Endo, Forest, Lilly, NeurogesX, Pfizer, Zogenix
Research: Endo, Forest, Lilly, NeurogesX, Pfizer
Speaker: Endo, Forest, Lilly, NeurogesX, Pfizer
Dr. Argoff discusses the unlabeled or investigational use of a commercial product.
Glenn J. Lesser, MD, FACP, has disclosed the following relevant financial relationship:
Advisory Board: Archimedes
Bill H. McCarberg, MD, has disclosed the following relevant financial relationships:
Speaker: Endo, Forest, NeurogesX, Pricara
Curatio CME Institute/Penn State College of Medicine
Thomas Finnegan, PhD, Associate Medical Director, has disclosed no relevant financial relationships.
Jonathan S. Simmons, ELS, Senior Managing Editor, has disclosed no relevant financial relationships.
Penn State staff members involved in the development and review of this activity have disclosed no relevant financial relationships.
For questions about CME credit for this activity, contact Penn State at ContinuingEd@hmc.psu.edu or (717) 531-6483. Reference course #G4372-12-T.
If you have any questions relating to your certificate or other issues with this activity, please contact myCME.Support@haymarketmedical.com.
The information presented at this activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a physician regarding diagnosis and treatment of a specific patient’s medical condition.
Support for this activity has been provided through an educational grant from Teva Pharmaceuticals.
Method of Participation
There are no fees for participating in this CME activity. To receive credit during the period August 22, 2012 to August 22, 2013, participants must (1) read the learning objectives and disclosure statements, (2) study the educational activity, and (3) complete the post-test and activity evaluation form, including the certificate information section.
To obtain a certificate, participants must receive a score of 70% or better on the post-test. The post-test can be accessed at the end of the activity.
Unapproved Product Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the US Food and Drug Administration. Penn State College of Medicine, Curatio CME Institute, and Teva Pharmaceuticals do not recommend the use of any agent outside the labeled indications.
The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Penn State College of Medicine, Curatio CME Institute, or Teva Pharmaceuticals. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Policy on Privacy and Confidentiality
Curatio CME Institute collects the information provided by the user. The information is used to notify users about upcoming programs and educational information that may be of interest. The information is not shared or used for commercial purposes unless prior permission has been granted by the user.
Curatio CME Institute may collect standard Web traffic data such as time and date of visit. Curatio CME Institute uses this information to administer its Web site. Browsing activity is recorded to form aggregate and anonymous demographic information, which is used as described above. Curatio CME Institute does not sell or offer to sell any user data, including registration and billing information, to any third parties for commercial purposes. Curatio CME Institute does, when required, provide the minimum subset of information to third parties that are responsible for accreditation of and issuance of certification for CME/CE tests. By participating in the Web-based activity, the user agrees that Curatio CME Institute has full permission to provide this minimum subset of information to the third parties as required by law.
WINDOWS PC SYSTEM REQUIREMENTS:
266-MHz Pentium II; Windows 98 or higher; 64 MB RAM; 800 x 600 screen resolution
set for “High Color (16-Bit)”; Macromedia Flash Player 6 or higher.
MACINTOSH® SYSTEM REQUIREMENTS:
Power Mac g3 at 300 MHz; System 8.5 or higher (excluding Mac OSX); 96 MB RAM; 20
MB minimum hard disk space available; 800 x 600 screen resolution set to “Thousands
of Colors”; Macromedia Flash Player 6 or higher.